AGI.do

Products

What will AGI do for Bexarotene?

This classification denotes a retinoic acid agent with the molecular formula C24H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A61RXM4375, chemically known as 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid but generally known as bexarotene, which bears US NIH Compound Identifier 82146. European Medicines Agency schedules Bexarotene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00795MIG. The term BEXAROTENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules bexarotene in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule bexarotene under HS 29163900 and SITC 51379. As of Q4 2014, BEXAROTENE remains the US FDA Preferred Term for this commodity. Bexarotene bears US NLM identifiers UMLS ID C0765273 and NCI Concept Code C1635. SMILES: OC(=O)C1CCC(C(=C)C2CC3C(CCC(C3CC2C)(C)C)(C)C)CC1.

How AGI delivers it

Four ways AGI delivers for Bexarotene

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bexarotene, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bexarotene, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bexarotene connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Particle Sizemodel
  • Particle Size Distributionmodel
  • Residual Solventmodel

Go deeper

Explore Bexarotene

Read the deeper take on agi.asView as markdown